Cytokine-induced memory-like (CIML) NK cells were generated by in vitro pre-activation with IL-12, IL-15, and IL-18 and showed promising responses in a Phase I trial in relapsed/refractory AML [119]. Here, IL15 is linked to acute myeloid leukemia.